The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCACP.
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCGP.
BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/
To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.
The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.
In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.
The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.
Target Audience: These recertification activities are intended for board-certified pharmacists seeking to update their knowledge and skills in:
- The current landscape of anti-amyloid medications for Alzheimer’s disease and mild cognitive impairment with an overall goal to close gaps in current practice related to the use of these medications
- Advancements in the pharmacologic management of urinary incontinence
- The use and selection of specific medication classes and agents in older adults and the BRACE tool to aid in selection of anti-hypertensives
- Addressing SUD in their practice and expand their knowledge of evidence-based practice specifically in the areas of alcohol use disorder (AUD) and opioid use disorder (OUD)
Betting on Progress: New Pharmacological Frontiers in Dementia Treatments - BCGP CreditActivity Number: 0204-9999-25-246-H01-P
Contact Hour(s): 1.00
Activity Type: Application BasedLearning ObjectivesBetting on Progress: New Pharmacological Frontiers in Dementia Treatments
- Identify appropriate patient populations for anti-amyloid medications based on clinical criteria, biomarkers, and disease stage.
- Explain the mechanisms, efficacy, and safety profile of anti-amyloid therapies, including potential adverse effects and monitoring requirements.
- Assess the understanding of interprofessional roles in managing patients receiving anti-amyloid treatment, focusing on collaboration between pharmacists, nurses, and physicians.
- Apply evidence-based clinical guidelines to make informed decisions on the initiation, monitoring, and management of anti-amyloid medications for Alzheimer’s and mild cognitive impairment (MCI) patients.
|
Urinary Incontinence in Adults: Optimizing Care with Current and Emerging Therapies - BCACP / BCGP CreditActivity Number: 0217-9999-25-150-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning ObjectivesUrinary Incontinence in Adults: Optimizing Care with Current and Emerging Therapies
- Recognize the different types of urinary incontinence based on patient symptoms and presentation.
- Evaluate current pharmacologic options for managing urinary incontinence, including their mechanisms of action, efficacy, and safety profile.
- Assess the clinical data on emerging therapies for urinary incontinence and their potential role in patient care.
- Formulate evidence-based treatment strategies for managing urinary incontinence in ambulatory care and geriatric populations.
|
The Pressure Puzzle: Tailoring Hypertension Therapy for Older Adults - BCACP / BCGP CreditActivity Number: 0204-9999-25-322-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning ObjectivesThe Pressure Puzzle: Tailoring Hypertension Therapy for Older Adults
- Discuss guidelines and clinical trials related to the optimal blood pressure goal in older adult patients.
- Compare and contrast blood pressure goals and their influence on MACE and other pertinent outcomes.
- Identify an appropriate blood pressure goal for an older adult using patient-specific factors, including frailty.
- Select an antihypertensive regimen for an older adult using the BRACE acronym and weighing the risk of medications against the risk of future events.
|
Rx for Recovery: Understanding and Treating Substance Use Disorders - BCACP / BCGP CreditActivity Number: 0217-9999-25-151-H01-P
Contact Hour(s): 1.50
Activity Type: Application BasedLearning ObjectivesRx for Recovery: Understanding and Treating Substance Use Disorders
- Evaluate current epidemiologic trends in substance use disorders in the United States.
- Apply universal screening techniques for substance use disorders.
- Develop a patient-centered and evidence-based harm reduction and treatment plan for alcohol use disorder.
- Develop a patient-centered and evidence-based harm reduction and treatment plan for opioid use disorder.
|
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.